These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19638534)

  • 1. A novel tumor-targeted therapy using a claudin-4-targeting molecule.
    Saeki R; Kondoh M; Kakutani H; Tsunoda S; Mochizuki Y; Hamakubo T; Tsutsumi Y; Horiguchi Y; Yagi K
    Mol Pharmacol; 2009 Oct; 76(4):918-26. PubMed ID: 19638534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of a claudin-targeting molecule using a C-terminal fragment of Clostridium perfringens enterotoxin.
    Ebihara C; Kondoh M; Hasuike N; Harada M; Mizuguchi H; Horiguchi Y; Fujii M; Watanabe Y
    J Pharmacol Exp Ther; 2006 Jan; 316(1):255-60. PubMed ID: 16183701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Claudin-4-targeting of diphtheria toxin fragment A using a C-terminal fragment of Clostridium perfringens enterotoxin.
    Kakutani H; Kondoh M; Saeki R; Fujii M; Watanabe Y; Mizuguchi H; Yagi K
    Eur J Pharm Biopharm; 2010 Jun; 75(2):213-7. PubMed ID: 20226859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of C-terminal regions of the C-terminal fragment of Clostridium perfringens enterotoxin in its interaction with claudin-4.
    Takahashi A; Kondoh M; Masuyama A; Fujii M; Mizuguchi H; Horiguchi Y; Watanabe Y
    J Control Release; 2005 Nov; 108(1):56-62. PubMed ID: 16091298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue distribution and safety evaluation of a claudin-targeting molecule, the C-terminal fragment of Clostridium perfringens enterotoxin.
    Li X; Saeki R; Watari A; Yagi K; Kondoh M
    Eur J Pharm Sci; 2014 Feb; 52():132-7. PubMed ID: 24231339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE).
    Santin AD; Bellone S; Marizzoni M; Palmieri M; Siegel ER; McKenney JK; Hennings L; Comper F; Bandiera E; Pecorelli S
    Cancer; 2007 Apr; 109(7):1312-22. PubMed ID: 17326053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A claudin-targeting molecule as an inhibitor of tumor metastasis.
    Saeki R; Kondoh M; Kakutani H; Matsuhisa K; Takahashi A; Suzuki H; Kakamu Y; Watari A; Yagi K
    J Pharmacol Exp Ther; 2010 Aug; 334(2):576-82. PubMed ID: 20442222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tyrosine residues in modulation of claudin-4 by the C-terminal fragment of Clostridium perfringens enterotoxin.
    Harada M; Kondoh M; Ebihara C; Takahashi A; Komiya E; Fujii M; Mizuguchi H; Tsunoda S; Horiguchi Y; Yagi K; Watanabe Y
    Biochem Pharmacol; 2007 Jan; 73(2):206-14. PubMed ID: 17097620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis.
    Takahashi A; Komiya E; Kakutani H; Yoshida T; Fujii M; Horiguchi Y; Mizuguchi H; Tsutsumi Y; Tsunoda S; Koizumi N; Isoda K; Yagi K; Watanabe Y; Kondoh M
    Biochem Pharmacol; 2008 Apr; 75(8):1639-48. PubMed ID: 18342294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal vaccination using claudin-4-targeting.
    Kakutani H; Kondoh M; Fukasaka M; Suzuki H; Hamakubo T; Yagi K
    Biomaterials; 2010 Jul; 31(20):5463-71. PubMed ID: 20398936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
    Santin AD; Cané S; Bellone S; Palmieri M; Siegel ER; Thomas M; Roman JJ; Burnett A; Cannon MJ; Pecorelli S
    Cancer Res; 2005 May; 65(10):4334-42. PubMed ID: 15899825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A toxicological evaluation of a claudin modulator, the C-terminal fragment of Clostridium perfringens enterotoxin, in mice.
    Suzuki H; Kondoh M; Li X; Takahashi A; Matsuhisa K; Matsushita K; Kakamu Y; Yamane S; Kodaka M; Isoda K; Yagi K
    Pharmazie; 2011 Jul; 66(7):543-6. PubMed ID: 21812332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in uterine carcinosarcomas.
    Santin AD; Bellone S; Siegel ER; McKenney JK; Thomas M; Roman JJ; Burnett A; Tognon G; Bandiera E; Pecorelli S
    Clin Cancer Res; 2007 Jun; 13(11):3339-46. PubMed ID: 17545541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium.
    Long H; Crean CD; Lee WH; Cummings OW; Gabig TG
    Cancer Res; 2001 Nov; 61(21):7878-81. PubMed ID: 11691807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of a mucosal vaccine using the C-terminal fragment of Clostridium perfringens enterotoxin.
    Suzuki H; Kakutani H; Kondoh M; Watari A; Yagi K
    Pharmazie; 2010 Oct; 65(10):766-9. PubMed ID: 21105580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors.
    Walther W; Petkov S; Kuvardina ON; Aumann J; Kobelt D; Fichtner I; Lemm M; Piontek J; Blasig IE; Stein U; Schlag PM
    Gene Ther; 2012 May; 19(5):494-503. PubMed ID: 21975465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Tyr306 in the C-terminal fragment of Clostridium perfringens enterotoxin for modulation of tight junction.
    Ebihara C; Kondoh M; Harada M; Fujii M; Mizuguchi H; Tsunoda S; Horiguchi Y; Yagi K; Watanabe Y
    Biochem Pharmacol; 2007 Mar; 73(6):824-30. PubMed ID: 17169334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutated C-terminal fragments of Clostridium perfringens enterotoxin have increased affinity to claudin-4 and reversibly modulate tight junctions in vitro.
    Takahashi A; Kondoh M; Uchida H; Kakamu Y; Hamakubo T; Yagi K
    Biochem Biophys Res Commun; 2011 Jul; 410(3):466-70. PubMed ID: 21672529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of N-terminal amino acids in the absorption-enhancing effects of the c-terminal fragment of Clostridium perfringens enterotoxin.
    Masuyama A; Kondoh M; Seguchi H; Takahashi A; Harada M; Fujii M; Mizuguchi H; Horiguchi Y; Watanabe Y
    J Pharmacol Exp Ther; 2005 Aug; 314(2):789-95. PubMed ID: 15870390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of an alanine-substituted mutant of the C-terminal fragment of Clostridium perfringens enterotoxin as a mucosal vaccine in mice.
    Suzuki H; Kondoh M; Kakutani H; Yamane S; Uchida H; Hamakubo T; Yagi K
    Biomaterials; 2012 Jan; 33(1):317-24. PubMed ID: 21983135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.